We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

ERBA MANNHEIM

Erba Mannheim is an IVD solutions provider focused on improving health outcomes in developing nations. Originally fou... read more Featured Products: More products

Download Mobile App





Erba Mannheim Makes SARS-CoV-2 Testing Available to Labs Everywhere

By LabMedica International staff writers
Posted on 03 Jul 2020
Erba Mannheim (London, England) has taken up the challenge of providing labs and clinicians everywhere with reliable and affordable solutions to SARS-CoV-2 testing.

The company’s efforts come amidst the serious challenges in the supply of material related to sampling and testing of SARS-CoV-2, as well as public confusion over the utility of some types of test. More...
With two main technologies emerging for SARS-CoV-2 testing: molecular (primarily PCR) and serology (ELISA, rapid tests, IFA), Erba has joined the fight against COVID-19 by launching the ErbaLisa IgG and IgM antibody ELISA kits. These tests have been developed and manufactured entirely in California, US by Calbiotech, the immunoassay center of excellence of the Erba Mannheim group.

Similar to its ErbaLisa ELISA range, Erba has continued to maintain quality and performance as the top priorities for its COVID-19 antibody assays. The IgG kits use Spike protein antigens to ensure clinical relevance and specificity, and the IgM kits employ a combination of Spike and Nucleocapsid antigens. Additionally, Erba has extensively validated the performance and accuracy of these tests through multiple studies in partnership with public and private laboratories, as well as universities. Aside from being CE marked, and pending EUA authorization in the US, the ErbaLisa COVID-19 tests have also been approved by strict regulatory bodies across the globe, from ANVISA in Brazil to the ICMR in India.

In addition to ensuring quality and performance of its ErbaLisa COVID-19 tests, Erba is now focusing on making these tests available to labs everywhere. The company remains committed to making quality diagnostic solutions affordable to growing labs across all the emerging markets in Asia, Latin America, the Middle East and Africa. Amidst the ongoing challenges in supply of reliable COVID-19 tests and long-standing IVD companies giving higher priority to meeting the demand in Europe and North America, Erba’s commitment to the emerging markets assumes greater significance.



Platinum Member
Fully Automatic ACLIA Analyzer
MAGLUMI X8
Gold Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.